2022
DOI: 10.1016/j.euros.2022.10.013
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of Survival Outcomes and Risk Factors Between Ductal Carcinoma of the Prostate and Acinar Adenocarcinoma of the Prostate: A Population-based Propensity Score–matching Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 23 publications
0
2
0
Order By: Relevance
“…The presence of UH has been considered to exhibit treatment resistance to intensitymodulated radiation therapy, androgen-deprivation therapy, and chemotherapy in addition to surgery 7,9,20 . Wei et al indicated that surgical treatment was a favorable option in patients with ductal carcinoma of the prostate as compared to radiation and/or hormonal therapy after PSM analysis 21 . Further investigation is warranted to identify better management options for hard-to-treat histological subtypes.…”
Section: Discussionmentioning
confidence: 99%
“…The presence of UH has been considered to exhibit treatment resistance to intensitymodulated radiation therapy, androgen-deprivation therapy, and chemotherapy in addition to surgery 7,9,20 . Wei et al indicated that surgical treatment was a favorable option in patients with ductal carcinoma of the prostate as compared to radiation and/or hormonal therapy after PSM analysis 21 . Further investigation is warranted to identify better management options for hard-to-treat histological subtypes.…”
Section: Discussionmentioning
confidence: 99%
“…The presence of UH has been considered to exhibit treatment resistance to intensity-modulated radiation therapy, androgen-deprivation therapy, and chemotherapy in addition to surgery 7 , 9 , 21 . Wei et al indicated that surgical treatment was a favorable option in patients with ductal carcinoma of the prostate as compared to radiation and/or hormonal therapy after PSM analysis 22 . Further investigation is warranted to identify better management options for hard-to-treat histological subtypes.…”
Section: Discussionmentioning
confidence: 99%
“…Prostatic ductal adenocarcinoma is a rare type of prostate cancer, but it is the second most common subtype of prostate cancer behind acinar adenocarcinoma, and on meta-analysis, 0.17% of cases were shown to be pure ductal type [ 11 ]. It is more commonly mixed with acinar adenocarcinoma, being present in 2.6% of prostatic adenocarcinomas [ 12 ] with a significantly higher risk of mortality than acinar adenocarcinoma [ 13 ]. It has a typical columnar cell type and often shows cribriform morphology.…”
Section: Introductionmentioning
confidence: 99%